- Total raised
- $45M
- Stage
- Series B
- Last round
- Feb 2026
- Hiring pace
- 5 roles / 90d
- Team size
- 51-200 employees
- Founded
- 2021
- HQ
- Lexington
About VulnCheck
VulnCheck provides vulnerability intelligence and exploit monitoring services for security teams.
Open roles · 5
- Open
Strategic Account Executive, Named
Boston, MA · hybrid
- Open
Sales Engineer - Israel
Tel Aviv Israel · remote
- Open
Sales Director - Israel
Tel Aviv Israel · remote
- Open
Senior Cloud Infrastructure Engineer (US)
Massachusetts, Maryland, · remote
- Open
Engineering Manager, Rapid Response Assignment - US
MA / Austin TX / MD · remote
Location
More startups in Lexington
Keros Therapeutics
Lexington
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Rapid Micro Biosystems
Lexington
Rapid Micro Biosystems is the leader in automated microbial contamination detection for pharmaceutical manufacturing
Genezen
Lexington
Bringing Therapies to Life
Space Tango
Lexington
Space Tango designs and builds hardware and software platforms that enable microgravity research.
MEDICILON USA
Lexington
Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China
MiNK Therapeutics
Lexington
MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.